Giorgio Gandaglia1, Briony Varda2, Akshay Sood3, Daniel Pucheril3, Ramdev Konijeti4, Jesse D Sammon3, Shyam Sukumar5, Mani Menon3, Maxine Sun5, Steven L Chang4, Francesco Montorsi6, Adam S Kibel4, Quoc-Dien Trinh4. 1. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC; ; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy; 2. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC; ; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital / Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; 3. Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI; 4. Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital / Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; 5. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC; 6. Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy;
Abstract
INTRODUCTION: We report the contemporary outcomes of radical cystectomy (RC) in patients with bladder cancer using a national, prospective perioperative database specifically developed to assess the quality of surgical care. METHODS: The National Surgical Quality Improvement Program (NSQIP) database was queried from 2006 to 2011 for RC. Data on postoperative complications, operative time, length of stay, blood transfusions, readmission, and mortality within 30 days from surgery were abstracted. RESULTS: Overall, 1094 patients undergoing RC were identified. Rates of overall complications, transfusions, prolonged length of hospitalization, readmission, and perioperative mortality were 31.1%, 34.4%, 25.9%, 20.2%, and 2.7%, respectively. Body mass index represented an independent predictor of overall complications on multivariate analysis (p = 0.04). Baseline comorbidity status was associated with increased odds of postoperative complications, prolonged operative time, transfusion, prolonged hospitalization, and perioperative mortality. In particular, patients with cardiovascular comorbidities were 2.4 times more likely to die within 30 days following cystectomy compared to their healthier counterparts (p = 0.04). Men had lower odds of prolonged operative time and blood transfusions (p ≤ 0.03). Finally, the receipt of a continent urinary diversion was the only predictor of readmission (p = 0.02). Our results are limited by their retrospective nature and by the lack of adjustment for hospital and tumour volume. CONCLUSIONS: Complications, transfusions, readmission, and perioperative mortality remain relatively common events in patients undergoing RC for bladder cancer. In an era where many advocate the need for prospective multi-institutional data collection as a means of improving quality of care, our study provides data on short-term outcomes after RC from a national quality improvement initiative.
INTRODUCTION: We report the contemporary outcomes of radical cystectomy (RC) in patients with bladder cancer using a national, prospective perioperative database specifically developed to assess the quality of surgical care. METHODS: The National Surgical Quality Improvement Program (NSQIP) database was queried from 2006 to 2011 for RC. Data on postoperative complications, operative time, length of stay, blood transfusions, readmission, and mortality within 30 days from surgery were abstracted. RESULTS: Overall, 1094 patients undergoing RC were identified. Rates of overall complications, transfusions, prolonged length of hospitalization, readmission, and perioperative mortality were 31.1%, 34.4%, 25.9%, 20.2%, and 2.7%, respectively. Body mass index represented an independent predictor of overall complications on multivariate analysis (p = 0.04). Baseline comorbidity status was associated with increased odds of postoperative complications, prolonged operative time, transfusion, prolonged hospitalization, and perioperative mortality. In particular, patients with cardiovascular comorbidities were 2.4 times more likely to die within 30 days following cystectomy compared to their healthier counterparts (p = 0.04). Men had lower odds of prolonged operative time and blood transfusions (p ≤ 0.03). Finally, the receipt of a continent urinary diversion was the only predictor of readmission (p = 0.02). Our results are limited by their retrospective nature and by the lack of adjustment for hospital and tumour volume. CONCLUSIONS: Complications, transfusions, readmission, and perioperative mortality remain relatively common events in patients undergoing RC for bladder cancer. In an era where many advocate the need for prospective multi-institutional data collection as a means of improving quality of care, our study provides data on short-term outcomes after RC from a national quality improvement initiative.
Authors: Brent K Hollenbeck; David C Miller; David Taub; Rodney L Dunn; Shukri F Khuri; William G Henderson; James E Montie; Willie Underwood; John T Wei Journal: J Urol Date: 2005-10 Impact factor: 7.450
Authors: Florian Roghmann; Shyam Sukumar; Praful Ravi; Vincent Q Trinh; Malek Meskawi; Khurshid R Ghani; Jesse D Sammon; Ariella A Friedman; James O Peabody; Mani Menon; Joachim Noldus; Pierre I Karakiewicz; Maxine Sun; Quoc-Dien Trinh Journal: Urol Int Date: 2013-09-19 Impact factor: 2.089
Authors: Vincent Q Trinh; Quoc-Dien Trinh; Zhe Tian; Jim C Hu; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz; Maxine Sun Journal: BJU Int Date: 2013-07 Impact factor: 5.588
Authors: Peter E Clark; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance C Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Philippe E Spiess; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho Journal: J Natl Compr Canc Netw Date: 2013-04-01 Impact factor: 11.908
Authors: Cheryl T Lee; Rodney L Dunn; Bert T Chen; Daya P Joshi; Jaqueline Sheffield; James E Montie Journal: J Urol Date: 2004-10 Impact factor: 7.450
Authors: C De Nunzio; L Cindolo; C Leonardo; A Antonelli; C Ceruti; G Franco; M Falsaperla; M Gallucci; M Alvarez-Maestro; A Minervini; V Pagliarulo; P Parma; S Perdonà; A Porreca; B Rocco; L Schips; S Serni; M Serrago; C Simeone; G Simone; R Spadavecchia; A Celia; P Bove; S Zaramella; S Crivellaro; R Nucciotti; A Salvaggio; B Frea; V Pizzuti; L Salsano; A Tubaro Journal: Eur J Surg Oncol Date: 2013-04-04 Impact factor: 4.424
Authors: D Robert Siemens; Melanie T Jaeger; Xuejiao Wei; Francisco Vera-Badillo; Christopher M Booth Journal: World J Urol Date: 2017-02-17 Impact factor: 4.226
Authors: Rashid K Sayyid; Diana Magee; Amanda E Hird; Benjamin T Harper; Eric Webb; Katherine L Fratino; Martha K Terris; Rabii Madi; Raj Satkunasivam; Christopher J D Wallis; Zachary Klaassen Journal: Can Urol Assoc J Date: 2021-01 Impact factor: 1.862
Authors: Briony K Varda; Ye Wang; Benjamin I Chung; Richard S Lee; Michael P Kurtz; Caleb P Nelson; Steven L Chang Journal: J Pediatr Urol Date: 2018-02-22 Impact factor: 1.830
Authors: Jeffrey J Leow; Jens Bedke; Karim Chamie; Justin W Collins; Siamak Daneshmand; Petros Grivas; Axel Heidenreich; Edward M Messing; Trevor J Royce; Alexander I Sankin; Mark P Schoenberg; William U Shipley; Arnauld Villers; Jason A Efstathiou; Joaquim Bellmunt; Arnulf Stenzl Journal: World J Urol Date: 2019-01-25 Impact factor: 4.226
Authors: Lee A Hugar; Tudor Borza; Mary K Oerline; Brent K Hollenbeck; Ted A Skolarus; Bruce L Jacobs Journal: Health Serv Res Date: 2019-12-26 Impact factor: 3.402
Authors: Katherine A Amin; Emily A Vertosick; Gillian Stearns; Ali Fathollahi; Daniel D Sjoberg; Machele S Donat; Harry Herr; Bernard Bochner; Guido Dalbagni; Jaspreet S Sandhu Journal: Urology Date: 2018-06-30 Impact factor: 2.649